Humacyte (HUMA) Shares Outstanding (Entity) (2020 - 2026)
Powered by 
Analysis
Humacyte (HUMA) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.36 Bn | 112.79 Mn | 29.60 Mn |
| 2 | CRISPR Therapeutics AG | 5.03 Bn | 5.03 Bn | - | 96.66 Mn |
| 3 | Iovance Biotherapeutics | 3.64 Bn | 3.35 Bn | 55.72 Mn | 452.97 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn | - |
| 5 | uniQure | 2.98 Bn | 2.98 Bn | 5.49 Mn | 69.33 Mn |
| 6 | Beam Therapeutics | 2.52 Bn | 2.52 Bn | - | 103.26 Mn |
| 7 | Precigen | 2.38 Bn | 2.38 Bn | 52.17 Mn | 358.01 Mn |
| 8 | Sarepta Therapeutics | 2.14 Bn | 1.35 Bn | 251.87 Mn | 105.62 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | 51.17 Mn |
| 10 | Humacyte | 134.35 Mn | 134.35 Mn | -825,000.00 | 277.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 277.80 Mn |
| Mar 31, 2026 | 222.02 Mn |
| Dec 31, 2025 | 158.16 Mn |
| Sep 30, 2025 | 158.84 Mn |
| Jun 30, 2025 | 156.34 Mn |
| Mar 31, 2025 | 155.12 Mn |
| Dec 31, 2024 | 130.03 Mn |
| Sep 30, 2024 | 119.84 Mn |
| Jun 30, 2024 | 119.35 Mn |
| Mar 31, 2024 | 119.08 Mn |
| Dec 31, 2023 | 103.67 Mn |
| Sep 30, 2023 | 103.46 Mn |
| Jun 30, 2023 | 103.41 Mn |
| Mar 31, 2023 | 103.33 Mn |
| Dec 31, 2022 | 103.23 Mn |
| Sep 30, 2022 | 103.10 Mn |
| Jun 30, 2022 | 103.01 Mn |
| Mar 31, 2022 | 103.00 Mn |
| Dec 31, 2021 | 39.97 Mn |
| Sep 30, 2021 | 43.95 Mn |